$0.930
+0.035 (+3.81%)Al cierre
Comparativa sectorial de GUTS
In the context of the broader market, GUTS competes directly with industry leaders such as BCDA and BIVI. With a market capitalization of $12.33M, it holds a significant position in the sector. When comparing efficiency, GUTS's gross margin of N/A stands against BCDA's N/A and BIVI's N/A. Such benchmarking helps identify whether Fractyl Health, Inc. is trading at a premium or discount relative to its financial performance.
Desempeño financiero de Fractyl Health Inc
Fractyl Health has shown no revenue generation in the last several quarters, with total revenue reported at 3,000 USD in Q4 2024 and a net income loss of -24,970,000 USD in the same quarter. The gross margin is currently at 100% but is not sustainable due to lack of revenue in subsequent quarters.
Financials
Artículos relacionados
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.